New NETWise Podcasts on NET Sites

Primary NET Site-Specific Episodes

Are you looking for more targeted information about your NET? Have you learned all the NET basics and, now, want a deeper understanding of information about your primary NET?

Beginning in August, the NETWise podcast is putting together primary site-specific episodes. NETs can arise almost anywhere in the body, but most start in the gastrointestinal tract, lung, and pancreas. The place where the NET first forms is called the primary site.

We recognize the different experiences of NET patients based on their primary NET. We plan to address these unique differences in individual episodes dedicated to lung NETs, small bowel NETs, and pancreatic NETs. We are working with NET specialists like Drs. Emily Bergsland, Aman Chauhan, Dan Halperin, Robert Ramirez, and others to put together these information-packed episodes.

If you are living with a primary NET other than what we listed above, don’t worry, we’ll eventually cover all the primary sites in special NETWise episodes.

Subscribe to our podcast:

Sign up to have NETRF notify you of the next NETWise podcast. Or, find and subscribe to NETWise on your favorite podcast service. 

Medical Disclaimer: This podcast is not intended as and shall not be relied upon as medical advice. The Neuroendocrine Tumor Research Foundation encourages all users to discuss any information found here with their oncologist, physician, and/or appropriate qualified health professional. Listening to this podcast does not constitute a patient-physician relationship. The Neuroendocrine Tumor Research Foundation does not represent that any information provided here should supplant the reasoned, informed advice of a patient’s oncologist, physician, or appropriate qualified health professional.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
0 0 vote
Article Rating
Subscribe
Notify of

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments